Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > RDW on youtube posted today

<< Previous

Bullboard Posts

Next >>

Comment by Alamir1111on Dec 02, 2023 4:40pm

184 Views

Post# 35765392

RE:RE:RE:RE:RE:RE:RE:RE:RDW on youtube posted today

So fda is waiting for the final 100 patients results before giving btd or aa just in case mid term data is not satisfactory? ?but we have open communication ?didn't we ? applie inI june for pre btd and we have clarification ??.6 months later still re applying for pre btd.. about 6 weeks upon pre btd approval we get response for btd.It's such simple procedure

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages